Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

Abstract Background To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary healthcare services (PHCS), improving accessibility, and, potentially, retenti...

Full description

Bibliographic Details
Main Authors: A. J. Wade, J. S. Doyle, E. Gane, C. Stedman, B. Draper, D. Iser, S. K. Roberts, W. Kemp, D. Petrie, N. Scott, P. Higgs, P. A. Agius, J. Roney, L. Stothers, A. J. Thompson, M. E. Hellard
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Trials
Subjects:
Community-based care
Hepatitis C virus
Randomized controlled trial
Protocol
Online Access:http://link.springer.com/article/10.1186/s13063-018-2768-3

Internet

http://link.springer.com/article/10.1186/s13063-018-2768-3

Similar Items